Risk communication: the science behind safety warnings

By  

Reactions Weekly, Vol. 1, Iss. 1425, 2012-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Development Safety Update Reports and Proposals for Effective and Efficient Risk Communication

By Urushihara Hisashi   Kawakami Koji  

Drug Safety, Vol. 33, Iss. 5, 2010-05 ,pp. : 341-352

Adis International

Access to resources Recommend Favorite

Effective Communication of Drug Safety Information to Patients and the Public: A New Look

By Vogt E.M.  

Drug Safety, Vol. 25, Iss. 5, 2002-01 ,pp. : 313-321

Adis International

Access to resources Recommend Favorite

Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events

By Yinon Yoav   Pauzner Rachel   Dulitzky Mordechai   Elizur Shai E   Dor Jehoshua   Shulman Adrian  

Reproductive BioMedicine Online, Vol. 12, Iss. 3, 2006-03 ,pp. : 354-358

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients

By Huillard Olivier   Boissier Emilie   Blanchet Benoit   Thomas-Schoemann Audrey   Cessot Anatole   Boudou-Rouquette Pascaline   Durand Jean-Philippe   Coriat Romain   Giroux Julie   Alexandre Jerome   Vidal Michel   Goldwasser Francois  

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 663-673

Informa Healthcare

Access to resources Recommend Favorite